Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, March 27, 2023.
Navidea Biopharmaceuticals, Inc. (AMEX:NAVB)
Weak Downtrend (-65) - NAVB is showing signs of a strengthening downtrend. Monitor NAVB as it may be building momentum to the downside.
Is it time to buy, sell, or avoid NAVB?
MarketClub looks at technical strength and momentum to determine if the timing is right for NAVB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NAVB
The long-term trend has been UP since Jan 19th, 2023 at 0.3250
The intermediate-term trend has been DOWN since Mar 24th, 2023 at 0.2701
The short-term trend has been DOWN since Mar 23rd, 2023 at 0.3000
Smart Scan Analysis for NAVB
Based on our trend formula, NAVB is rated as a -70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
-70
Strong Downtrend
Sideways
Strong Uptrend
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.2800 | 0.2801 | 0.2800 | 0.2801 | -0.0099 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.2900 | 2952 | 2023-03-27 09:50:57 |
| Year High | 0.4242 | Year High Date | 2018-03-09 |
| Year Low | 0.125 | Year Low Date | 2018-08-16 |
| 52wk High | 1.24 | 52wk High Date | 2022-04-19 |
| 52wk Low | 0.16 | 52wk Low Date | 2022-12-28 |
| Year End Close | 2.83 | Average Volume | 70,092 |
| Shares Outstanding | 32,364 | Short Interest | 18,176,460 |
| % Institutional | 24.5 | Market Cap | 13M |
| Assets | 6,258,432M | Liabilities | 11,218,065M |
| P/E Ratio | -3.37500000 | Beta | 0.92 |
| Volatility | 87.14 |
Get a free daily analysis and signals for Navidea Biopharmaceuticals, Inc. (NAVB) - Request Your Free Report.